PRF Technologies Ltd. PRFX NASDAQ

NASDAQ Capital Marke • Healthcare • Drug Manufacturers - Specialty & Generic • IL • USD

SharesGrow Score

21/100

0/6 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

PRF Technologies Ltd. (PRFX) has a negative trailing P/E of -0.1, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 0.1 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -1,590.48%, forward earnings yield 714.29%.

Criteria proven by this page:

VALUE (0/100, Fail) — negative P/E indicates the company is currently operating at a loss — DCF and P/E-based valuation models cannot produce meaningful results for unprofitable companies (P/E -0.1); trailing earnings yield is below the 10-year Treasury yield (~4.3%), meaning bonds offer a better return (EY -1,590.48%).
Forward P/E 0.1 — analysts expect a return to profitability with estimated EPS of $19.20 for FY2028.
Trailing Earnings Yield -1,590.48% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 714.29% as earnings recover.

Overall SharesGrow Score: 21/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

21/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

✗

FUTURE

20/100

Analyst consensus

→ Forecast

✗

PAST

0/100

→ Income

HEALTH

67/100

Debt-to-Equity & liquidity

→ Health

✗

MOAT

0/100

→ Income

✗

GROWTH

30/100

→ Income

✗

INCOME

10/100

→ Income

Valuation Snapshot — PRFX

Valuation Multiples

P/E (TTM)-0.1

Forward P/E0.1

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.02

P/S Ratio0.00

EV/EBITDA1.0

Per Share Data

EPS (TTM)$-37.69

Forward EPS (Est.)$19.20

Book Value / Share$109.40

Revenue / Share$0.00

FCF / Share$-46.76

Yields & Fair Value

Earnings Yield-1,590.48%

Forward Earnings Yield714.29%

Dividend Yield0.00%

Historical Valuation

Year	P/E (TTM)	PEG Ratio	P/B Ratio	P/S Ratio	Dividend Yield
2017	-2.2	0.00	-1.27	0.00	-
2018	-5.6	0.09	-1.03	0.00	-
2019	-1.7	-0.01	-0.56	0.00	-
2020	-0.6	-0.02	0.16	0.00	-
2021	-0.1	0.00	0.04	0.00	-
2022	0.0	0.00	0.02	2.56	-
2023	0.0	0.00	0.02	0.00	-
2024	0.0	0.00	0.17	0.00	-
2025	-0.4	0.00	0.24	122.35	-

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2017	$-36.25	$0.00	$-2.09M	-
2018	$-1.43	$0.00	$-828K	-
2019	$-1.96	$0.00	$-1.82M	-
2020	$-3.46	$0.00	$-4.05M	-
2021	$-7.38	$0.00	$-7.25M	-
2022	$-8.25	$86K	$-8.79M	-10223.3%
2023	$-42.83	$0.00	$-9.34M	-
2024	$-32.16	$0.00	$-14.59M	-
2025	$-7.47	$17K	$-4.84M	-28458.8%

Analyst Estimates

Year	EPS (Avg)	EPS Range	Revenue (Avg)	Revenue Range	Analysts
2026	$-176.40	$-176.40 – $-176.40	$10.31M	$10.31M – $10.31M	1
2027	$-129.60	$-129.60 – $-129.60	$11.02M	$11.02M – $11.02M	1
2028	$19.20	$19.20 – $19.20	$37.26M	$37.26M – $37.26M	1